Diatech Diabetes is a developer of monitoring systems to personalize insulin delivery for patients with diabetes.
Diatech Diabetes has raised $100K in total funding. The most recent round was Debt Financing. The last funding was announced in July 2024.
Diatech Diabetes's investors include Breakthrough T1D, Right Side Capital Management, ZeroTo510, Consortium For Technology & Innovation in Pediatrics.
Diatech Diabetes is headquartered in Memphis, United States.
Diatech Diabetes is a developer of monitoring systems to personalize insulin delivery for patients with diabetes.
Diatech Diabetes is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Diatech Diabetes — Funding & Investors." VCBacked, July 25, 2024, https://www.vcbacked.co/company/diatech-diabetes. Accessed July 20, 2026.
VCBacked. (2024). Diatech Diabetes — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/diatech-diabetes
{{cite web |title=Diatech Diabetes — Funding & Investors |url=https://www.vcbacked.co/company/diatech-diabetes |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated